Morrison Foerster
  • People
  • Capabilities
    PracticesIndustriesRegions
  • Resources
    InsightsNewsEventsBlogsPodcastsVideo + Audio
  • About
    Chair, Vice Chairs, COOOur ValuesHonors + AwardsPress Contacts
  • Culture
    MoFo WomenDiversityMoFo FoundationPro Bono
  • Offices
  • Careers
  • Alumni
  • Contact
Stay Connected
Blog Post

Prevent a Clinical Trial from Turning Into a Criminal Trial

MoFo Life Sciences

15 Nov 2022
  • Email

On November 2, 2022, Stacy Cline Amin, former Chief Counsel of the U.S. Food and Drug Administration (FDA) and Deputy General Counsel of the Department of Health and Human Services (HHS), moderated the panel “Compliance and Cybersecurity Challenges in Clinical Trial Enforcement,” during the Food and Drug Law Institute’s Clinical Trials: Deconstructing Challenges and Providing Practical Insights Conference. The panel featured a high-ranking attorney from the Department of Justice’s (DOJ) Consumer Protection Branch (CPB) and other regulatory compliance leaders to discuss key trends and issues in clinical trial enforcement that underscored the need to ensure appropriate compliance measures are in place to avoid future investigations.

Read the full blog post.

  • Stacy Cline Amin
    Stacy Cline Amin
    Partner
  • Kate Driscoll
    Kate Driscoll
    Of Counsel
  • Brian K. Kidd
    Brian K. Kidd
    Partner
  • Brian R. Michael
    Brian R. Michael
    Partner

Practices

  • FDA + Healthcare Regulatory and Compliance

Industries

  • Life Sciences + Healthcare
  • Terms / Notices
  • Cookies
  • Privacy Policy
  • Attorney Advertising
  • Secure Login
  • Alumni

©1996–2023 Morrison & Foerster LLP. All rights reserved.